Heparan Sulfate Proteoglycan–Involving Immunomodulation by Cathelicidin Antimicrobial Peptides LL-37 and PR-39
Author(s) -
Nicole C. Kaneider,
Angela Djanani,
Christian J. Wiedermann
Publication year - 2007
Publication title -
the scientific world journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.453
H-Index - 93
eISSN - 2356-6140
pISSN - 1537-744X
DOI - 10.1100/tsw.2007.285
Subject(s) - cathelicidin , antimicrobial peptides , peptide , peptide sequence , innate immune system , biochemistry , beta defensin , biology , defensin , effector , amino acid , antimicrobial , chemistry , microbiology and biotechnology , receptor , gene
Antimicrobial peptides, which are categorized by homologous structural motifs, are effector molecules of innate immunity with direct antimicrobial activity and multiple other functions. The most prominent families are defensins and cathelicidins. These peptides are expressed in the granules of several types of leukocytes and in a wide variety of tissue types[1]. Peptide antibiotics of the cathelicidin family are characterized by a highly conserved signal sequence and proregions (“cathelin” = cathepsin L inhibitor), but show substantial heterogeneity in the carboxy-terminal domain that encodes the mature peptide[2,3,4]. Based on amino acid sequences, cathelicidin peptides are categorized in (a) linear, a-helical peptides without cysteines, e.g., LL-37/human cathelicidin antimicrobial peptide (hCAP)-18 from human; (b) peptides with an even number of cysteines linked by disulfide bridges, e.g., protegrins (porcine cathelicidin peptides); and (c) peptides with an unusually high proportion of one or two amino acids, e.g., PR-39 from porcine leukocytes (Table 1).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom